Clinical Trials Browser

Recruiting × Recurrence × iberdomide × Clear all

NCT06215118 2026-05-22

MagnetisMM-30

Phase 1 Recruiting

Multiple Myeloma, Recurrence

NCT06518551 2025-12-11

Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM

Phase 1/2 Recruiting

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell